MeSH tree: D02.092.063.700
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses ...
Sep 23, 2025
0
15
In his recent doctoral thesis, defended at the University of Helsinki, Matej Zore investigated two drugs, fingolimod and etrasimod—initially developed to treat autoimmune diseases—for their potential to fight drug-resistant ...
Nov 18, 2024
0
17
with a close family member living with multiple sclerosis Stephen J. Crocker, Ph.D., associate professor of neuroscience and immunology at UConn School of Medicine, takes his research personally.
Jul 30, 2024
0
37
A study aiming to deliver Fingolimod (FTY720) loaded polymer scaffolds to enhance oral wound healing by modulating pro-regenerative immune cell migration associated with improved vascularization and tissue remodeling was ...
Mar 19, 2024
0
30
For decades, scientists have noted an intriguing similarity between a deficiency in vitamin B12—an essential nutrient that supports healthy development and functioning of the central nervous system (CNS)—and multiple sclerosis ...
Dec 11, 2023
0
221
Degeneration of myelin, an insulating sheath required for rapid communication between nerve cells, and neuroinflammation are notable hallmarks of Multiple Sclerosis (MS) and related neurodegenerative disorders such as Alzheimer's ...
Apr 20, 2023
0
127
Nearly two dozen experimental therapies targeting the immune system are in clinical trials for Alzheimer's disease, a reflection of the growing recognition that immune processes play a key role in driving the brain damage ...
Mar 8, 2023
0
74
Monash University researchers have used the world's largest multiple sclerosis (MS) registry, MSBase, to provide evidence that will help those with MS take the best medicine for them.
Nov 7, 2022
0
53
